OTC Healthcare in the US to 2014

Introduction

This databook provides key data and information on the OTC healthcare market in the US. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share.

Scope

*Contains information on:analgesics,medicated skinproduct,topicalOTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits

*Market,category and segment level information on value with historic (2004-09) and forecast (2010-14) data

*Category level company and brand share as well as distribution share information for 2008 and 2009

*Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description

Highlights

The market for OTC healthcare in the US increased at a compound annual growth rate of 3.4% between 2004 and 2009.

The cough and cold preparations category led the OTC healthcare market in the US, accounting for a share of 22%.

Leading players in US OTC healthcare market include Johnson & Johnson, Wyeth and Procter & Gamble Company, The.

Reasons to Purchase

*Develop business strategies by understanding the quantitative trends within the OTC healthcare market in the US

*Design effective marketing and sales strategies by identifying key market categories and segments

*Identify key players within the market to plan lucrative M&A, partnerships and agreements


Report Highlights

[Studien Infos ausblenden]

TABLE OF CONTENTS
Chapter 1 Executive Summary 2
Summary market level: OTC healthcare 2
Summary category level: analgesics 3
Summary category level: topical OTC medicines 4
Summary category level: cough and cold preparations 5
Summary category level: indigestion preparations 6
Summary category level: medicated skin products 7
Summary category level: first aid kits 8
Summary category level: other OTC healthcare products 9
Summary category level: plasters & bandages 10
Summary category level: traditional medicines 11
Summary category level: vitamins and minerals 12
Chapter 2 Introduction 13
What is this report about? 13
How to use this report 13
Market definition 14
Chapter 3 Market Overview 29
Value analysis (US Dollar), 2004?09 29
Value analysis (US Dollar), 2009?14 31
Company and brand share analysis 34
Distribution analysis 43
Chapter 4 Leading Company Profiles 45
Johnson & Johnson 45
Wyeth 47
Chapter 5 Category Analysis: Analgesics 49
Value analysis (US Dollar), 2004?09 49
Value analysis (US Dollar), 2009?14 50
Company and brand share analysis 52
Distribution analysis 56
Chapter 6 Category Analysis: Topical OTC Medicines 58
Value analysis (US Dollar), 2004?09 58
Value analysis (US Dollar), 2009?14 59
Company and brand share analysis 61
Distribution analysis 63
Chapter 7 Category Analysis: Cough and Cold Preparations 65
Value analysis (US Dollar), 2004?09 65
Value analysis (US Dollar), 2009?14 66
Company and brand share analysis 68
Distribution analysis 73
Chapter 8 Category Analysis: Indigestion Preparations 75
Value analysis (US Dollar), 2004?09 75
Value analysis (US Dollar), 2009?14 76
Company and brand share analysis 78
Distribution analysis 82
Chapter 9 Category Analysis: Medicated Skin Products 84
Value analysis (US Dollar), 2004?09 84
Value analysis (US Dollar), 2009?14 85
Company and brand share analysis 87
Distribution analysis 91
Chapter 10 Category Analysis: First Aid Kits 93
Value analysis (US Dollar), 2004?09 93
Value analysis (US Dollar), 2009?14 94
Company and brand share analysis 95
Distribution analysis 98
Chapter 11 Category Analysis: Other OTC Healthcare Products 100
Value analysis (US Dollar), 2004?09 100
Value analysis (US Dollar), 2009?14 101
Company and brand share analysis 103
Distribution analysis 108
Chapter 12 Category Analysis: Plasters & Bandages 110
Value analysis (US Dollar), 2004?09 110
Value analysis (US Dollar), 2009?14 111
Company and brand share analysis 113
Distribution analysis 116
Chapter 13 Category Analysis: Traditional Medicines 118
Value analysis (US Dollar), 2004?09 118
Value analysis (US Dollar), 2009?14 119
Company and brand share analysis 120
Distribution analysis 122
Chapter 14 Category Analysis: Vitamins and Minerals 124
Value analysis (US Dollar), 2004?09 124
Value analysis (US Dollar), 2009?14 125
Company and brand share analysis 127
Distribution analysis 130
Chapter 15 Country Comparison 132
Value 132
Market share 136
Chapter 16 New Product Development 137
Product launches over time 137
Recent product launches 139
Chapter 17 Macroeconomic Profile 140
Macroeconomic Indicators 140
Chapter 18 Research Methodology 145
Methodology overview 145
Secondary research 146
Market modeling 147
Creating an initial data model 147
Revising the initial data model 147
Creating a final estimate 148
Creating demographic value splits 148
Primary research 148
Data finalization 149
Ongoing research 149
Chapter 19 Appendix 150
Future readings 150
How to contact experts in your industry 150
Disclaimer 150

LIST OF FIGURES
Figure 1: OTC healthcare, US, value by category ($m), 2004?14 32
Figure 2: OTC healthcare, US, category growth comparison, by value, 2004?14 33
Figure 3: OTC healthcare, US, company share by value (%), 2008?09 40
Figure 4: OTC healthcare, US, distribution channels by value (%), 2008?09 44
Figure 5: Analgesics, US, value by segment ($m), 2004?14 51
Figure 6: Analgesics, US, category growth comparison, by value, 2004?14 51
Figure 7: Analgesics, US, company share by value (%), 2008?09 54
Figure 8: Analgesics, US, distribution channels by value (%), 2008?09 57
Figure 9: Topical OTC medicines, US, value by segment ($m), 2004?14 60
Figure 10: Topical OTC medicines, US, category growth comparison, by value, 2004?14 60
Figure 11: Topical OTC medicines, US, distribution channels by value (%), 2008?09 64
Figure 12: Cough and cold preparations, US, value by segment ($m), 2004?14 67
Figure 13: Cough and cold preparations, US, category growth comparison, by value, 2004?14 67
Figure 14: Cough and cold preparations, US, company share by value (%), 2008?09 70
Figure 15: Cough and cold preparations, US, distribution channels by value (%), 2008?09 74
Figure 16: Indigestion preparations, US, value by segment ($m), 2004?14 77
Figure 17: Indigestion preparations, US, category growth comparison, by value, 2004?14 77
Figure 18: Indigestion preparations, US, company share by value (%), 2008?09 80
Figure 19: Indigestion preparations, US, distribution channels by value (%), 2008?09 83
Figure 20: Medicated skin products, US, value by segment ($m), 2004?14 86
Figure 21: Medicated skin products, US, category growth comparison, by value, 2004?14 86
Figure 22: Medicated skin products, US, company share by value (%), 2008?09 89
Figure 23: Medicated skin products, US, distribution channels by value (%), 2008?09 92
Figure 24: First aid kits, US, value ($m), 2004?14 94
Figure 25: First aid kits, US, company share by value (%), 2008?09 96
Figure 26: First aid kits, US, distribution channels by value (%), 2008?09 99
Figure 27: Other OTC healthcare products, US, value by segment ($m), 2004?14 102
Figure 28: Other OTC healthcare products, US, category growth comparison, by value, 2004?14 102
Figure 29: Other OTC healthcare products, US, company share by value (%), 2008?09 105
Figure 30: Other OTC healthcare products, US, distribution channels by value (%), 2008?09 109
Figure 31: Plasters & bandages, US, value by segment ($m), 2004?14 112
Figure 32: Plasters & bandages, US, category growth comparison, by value, 2004?14 112
Figure 33: Plasters & bandages, US, company share by value (%), 2008?09 114
Figure 34: Plasters & bandages, US, distribution channels by value (%), 2008?09 117
Figure 35: Traditional medicines, US, value ($m), 2004?14 119
Figure 36: Traditional medicines, US, distribution channels by value (%), 2008?09 123
Figure 37: Vitamins and minerals, US, value by segment ($m), 2004?14 126
Figure 38: Vitamins and minerals, US, category growth comparison, by value, 2004?14 126
Figure 39: Vitamins and minerals, US, company share by value (%), 2008?09 128
Figure 40: Vitamins and minerals, US, distribution channels by value (%), 2008?09 131
Figure 41: Global OTC healthcare market split (value terms, 2009), top five countries 133
Figure 42: Global OTC healthcare market value, 2004Ð09, top five countries 135
Figure 43: Annual data review process 146

LIST OF TABLES
Table 1: OTC healthcare category definitions 15
Table 2: OTC healthcare distribution channels 17
Table 3: OTC healthcare, US, value by category ($m), 2004?09 30
Table 4: OTC healthcare, US, value forecast by category ($m), 2009?14 31
Table 5: OTC healthcare, US, brand share by value (%), 2008?09 34
Table 6: OTC healthcare, US, value by brand ($m), 2008?09 37
Table 7: OTC healthcare, US, company share by value (%), 2008?09 41
Table 8: OTC healthcare, US, value by company ($m), 2008?09 42
Table 9: OTC healthcare, US, distribution channels by value (%), 2008?09 43
Table 10: OTC healthcare, US, value by distribution channel ($m), 2008?09 43
Table 11: Johnson & Johnson key facts 45
Table 12: Wyeth key facts 47
Table 13: Analgesics, US, value by segment ($m), 2004?09 49
Table 14: Analgesics, US, value forecast by segment ($m), 2009?14 50
Table 15: Analgesics, US, brand share by value (%), 2008?09 52
Table 16: Analgesics, US, value by brand ($m), 2008?09 53
Table 17: Analgesics, US, company share by value (%), 2008?09 55
Table 18: Analgesics, US, value by company ($m), 2008?09 55
Table 19: Analgesics, US, distribution channels by value (%), 2008?09 56
Table 20: Analgesics, US, value by distribution channel ($m), 2008?09 56
Table 21: Topical OTC medicines, US, value by segment ($m), 2004?09 58
Table 22: Topical OTC medicines, US, value forecast by segment ($m), 2009?14 59
Table 23: Topical OTC medicines, US, brand share by value (%), 2008?09 61
Table 24: Topical OTC medicines, US, value by brand ($m), 2008?09 61
Table 25: Topical OTC medicines, US, company share by value (%), 2008?09 62
Table 26: Topical OTC medicines, US, value by company ($m), 2008?09 62
Table 27: Topical OTC medicines, US, distribution channels by value (%), 2008?09 63
Table 28: Topical OTC medicines, US, value by distribution channel ($m), 2008?09 63
Table 29: Cough and cold preparations, US, value by segment ($m), 2004?09 65
Table 30: Cough and cold preparations, US, value forecast by segment ($m), 2009?14 66
Table 31: Cough and cold preparations, US, brand share by value (%), 2008?09 68
Table 32: Cough and cold preparations, US, value by brand ($m), 2008?09 69
Table 33: Cough and cold preparations, US, company share by value (%), 2008?09 71
Table 34: Cough and cold preparations, US, value by company ($m), 2008?09 72
Table 35: Cough and cold preparations, US, distribution channels by value (%), 2008?09 73
Table 36: Cough and cold preparations, US, value by distribution channel ($m), 2008?09 73
Table 37: Indigestion preparations, US, value by segment ($m), 2004?09 75
Table 38: Indigestion preparations, US, value forecast by segment ($m), 2009?14 76
Table 39: Indigestion preparations, US, brand share by value (%), 2008?09 78
Table 40: Indigestion preparations, US, value by brand ($m), 2008?09 79
Table 41: Indigestion preparations, US, company share by value (%), 2008?09 81
Table 42: Indigestion preparations, US, value by company ($m), 2008?09 81
Table 43: Indigestion preparations, US, distribution channels by value (%), 2008?09 82
Table 44: Indigestion preparations, US, value by distribution channel ($m), 2008?09 82
Table 45: Medicated skin products, US, value by segment ($m), 2004?09 84
Table 46: Medicated skin products, US, value forecast by segment ($m), 2009?14 85
Table 47: Medicated skin products, US, brand share by value (%), 2008?09 87
Table 48: Medicated skin products, US, value by brand ($m), 2008?09 88
Table 49: Medicated skin products, US, company share by value (%), 2008?09 90
Table 50: Medicated skin products, US, value by company ($m), 2008?09 90
Table 51: Medicated skin products, US, distribution channels by value (%), 2008?09 91
Table 52: Medicated skin products, US, value by distribution channel ($m), 2008?09 91
Table 53: First aid kits, US, value ($m), 2004?09 93
Table 54: First aid kits, US, value forecast ($m), 2009?14 94
Table 55: First aid kits, US, brand share by value (%), 2008?09 95
Table 56: First aid kits, US, value by brand ($m), 2008?09 95
Table 57: First aid kits, US, company share by value (%), 2008?09 97
Table 58: First aid kits, US, value by company ($m), 2008?09 97
Table 59: First aid kits, US, distribution channels by value (%), 2008?09 98
Table 60: First aid kits, US, value by distribution channel ($m), 2008?09 98
Table 61: Other OTC healthcare products, US, value by segment ($m), 2004?09 100
Table 62: Other OTC healthcare products, US, value forecast by segment ($m), 2009?14 101
Table 63: Other OTC healthcare products, US, brand share by value (%), 2008?09 103
Table 64: Other OTC healthcare products, US, value by brand ($m), 2008?09 104
Table 65: Other OTC healthcare products, US, company share by value (%), 2008?09 106
Table 66: Other OTC healthcare products, US, value by company ($m), 2008?09 107
Table 67: Other OTC healthcare products, US, distribution channels by value (%), 2008?09 108
Table 68: Other OTC healthcare products, US, value by distribution channel ($m), 2008?09 108
Table 69: Plasters & bandages, US, value by segment ($m), 2004?09 110
Table 70: Plasters & bandages, US, value forecast by segment ($m), 2009?14 111
Table 71: Plasters & bandages, US, brand share by value (%), 2008?09 113
Table 72: Plasters & bandages, US, value by brand ($m), 2008?09 113
Table 73: Plasters & bandages, US, company share by value (%), 2008?09 115
Table 74: Plasters & bandages, US, value by company ($m), 2008?09 115
Table 75: Plasters & bandages, US, distribution channels by value (%), 2008?09 116
Table 76: Plasters & bandages, US, value by distribution channel ($m), 2008?09 116
Table 77: Traditional medicines, US, value ($m), 2004?09 118
Table 78: Traditional medicines, US, value forecast ($m), 2009?14 119
Table 79: Traditional medicines, US, brand share by value (%), 2008?09 120
Table 80: Traditional medicines, US, value by brand ($m), 2008?09 120
Table 81: Traditional medicines, US, company share by value (%), 2008?09 121
Table 82: Traditional medicines, US, value by company ($m), 2008?09 121
Table 83: Traditional medicines, US, distribution channels by value (%), 2008?09 122
Table 84: Traditional medicines, US, value by distribution channel ($m), 2008?09 122
Table 85: Vitamins and minerals, US, value by segment ($m), 2004?09 124
Table 86: Vitamins and minerals, US, value forecast by segment ($m), 2009?14 125
Table 87: Vitamins and minerals, US, brand share by value (%), 2008?09 127
Table 88: Vitamins and minerals, US, value by brand ($m), 2008?09 127
Table 89: Vitamins and minerals, US, company share by value (%), 2008?09 129
Table 90: Vitamins and minerals, US, value by company ($m), 2008?09 129
Table 91: Vitamins and minerals, US, distribution channels by value (%), 2008?09 130
Table 92: Vitamins and minerals, US, value by distribution channel ($m), 2008?09 130
Table 93: Global OTC healthcare market value, 2009 132
Table 94: Global OTC healthcare market split (value terms ($m), 2009), top five countries 135
Table 95: Leading players, top five countries 136
Table 96: US OTC healthcare new product launches reports, by company (top five companies), 2009 137
Table 97: US OTC healthcare new product launches SKUs, by company (top five companies), 2009 137
Table 98: US OTC healthcare new product launches (reports), by flavor and fragrances (top 10 flavors), 2009 138
Table 99: US OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2009 138
Table 100: US OTC healthcare new product launches (reports), by package tags or claims (top 10 claims), 2009 139
Table 101: US OTC healthcare new product launches - recent five launches (2009) 139
Table 102: US population, by age group, 2004?09 (millions) 140
Table 103: US population forecast, by age group, 2009?14 (millions) 141
Table 104: US population, by gender, 2004?09 (millions) 141
Table 105: US population forecast, by gender, 2009?14 (millions) 142
Table 106: US nominal GDP, 2004?09 ($bn, nominal prices) 142
Table 107: US nominal GDP forecast, 2009?14 ($bn, nominal prices) 142
Table 108: US real GDP, 2004?09 ($bn, 2000 prices) 143
Table 109: US real GDP forecast, 2009?14 ($bn, 2000 prices) 143
Table 110: US consumer price index, 2004?09 (2000=100) 144
Table 111: US consumer price index, 2009?14 (2000=100) 144



[Inhaltsverzeichnis ausblenden]